[A26-82] Colchicine (prophylaxis of ischaemic cardiovascular events after myocardial infarction) – Addendum to Project A26-16
Last updated 20.08.2026
Project no.:
A26-82
Commission:
Commission awarded on 07.07.2026 by the Federal Joint Committee (G-BA).
Report type:
Addendum
Status:
Commission completed
Department/Division:
Drug Assessment
Topic:
Heart and circulation
In addition to standard therapies for prophylaxis of ischaemic cardiovascular events in adult patients with atherosclerotic coronary artery disease and a recent myocardial infarction
Unchanged after addendum: hint of a non-quantifiable added benefit
If the need for additional work on a project commissioned by the G-BA arises during consultations, IQWiG submits an addendum. The subsequent decides on the extent of the added benefit concludes the early benefit assessment.
https://doi.org/10.60584/A26-82
| Project no. | Title | Status |
|---|---|---|
| A26-16 | Colchicine (prophylaxis of ischaemic cardiovascular events after myocardial infarction) – Benefit assessment according to §35a Social Code Book V | Commission completed |
Federal Joint Committee (G-BA)
20-08-2026 A G-BA decision was published.
G-BA documents on this decision